Alphyn Biologics: Funding, Investors & Team (Sep 2026)
Alphyn Biologics is a life science company that specializes in creating exclusive drug treatments for skin ailments. The company's primary focus is on using their unique Multi-Target Therapeutic plant-based technology to address skin infections caused by tough-to-treat MRSA bacteria.
Alphyn Biologics has raised $33.5M across 3 funding rounds on record, the most recent a Series B of $25.0M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alphyn Biologics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Alphyn Biologics Funding Rounds
Alphyn Biologics raised $3.3M in a Series A announced in Sep 2022.
1.6 years later, an undisclosed round of $5.2M was announced in Apr 2024.
1.7 years later, a Series B of $25.0M was announced in Dec 2025.
Alphyn Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Alphyn Biologics Funding Compared to Other Biotechnology Startups
Alphyn Biologics' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alphyn Biologics in Biotechnology and Cincinnati
Companies Similar to Alphyn Biologics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Alphyn Biologics Funding FAQs
What does Alphyn Biologics do?
Alphyn Biologics is a life science company that specializes in creating exclusive drug treatments for skin ailments. The company's primary focus is on using their unique Multi-Target Therapeutic plant-based technology to address skin infections caused by tough-to-treat MRSA bacteria.
How much funding has Alphyn Biologics raised?
Alphyn Biologics has raised $33.5M across 3 rounds on record. The most recent is a Series B of $25.0M announced in Dec 2025.
When did Alphyn Biologics last raise funding?
Alphyn Biologics' most recent funding round on record is a Series B of $25.0M, announced in Dec 2025.
Who founded Alphyn Biologics?
FundedIQ lists Neal Koller (Founder) at Alphyn Biologics.
Where is Alphyn Biologics headquartered?
Alphyn Biologics is based in Cincinnati, Ohio, United States.
How many employees does Alphyn Biologics have?
Alphyn Biologics is in the 1-10 employee band.
How does Alphyn Biologics' funding compare to other Biotechnology startups?
Alphyn Biologics' latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Alphyn Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alphyn Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.